Animal fats firm Synthase Biotech goes bust owing $3.5m

Animal fats firm Synthase Biotech goes bust owing $3.5m
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
An animal breeding startup has collapsed after failing to find enough commercial contracts for its product and cash to keep the operation going.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise, of $800,000, in 2016.Its trademarked enzyme Aloxsyn had been shown to extend the life of fr...

More Primary Sector

Potential Mainland buyers may soon tap regulators
Primary Sector

Potential Mainland buyers may soon tap regulators

Fonterra's divestment process is gaining traction.

Riley Kennedy 17 Apr 2025
TTR files fast-track application to mine Taranaki sand
Primary Sector

TTR files fast-track application to mine Taranaki sand

Seabed mining firm Trans-Tasman Resources has lodged its application to fast-track its project to harvest iron sands off the coast of Taranaki. The firm's parent company, Manuka Resources, told the Australian Securities Exchange (NZX) on Wednesday that the application was lod...

Staff reporters 16 Apr 2025
Scott Technology's revenue drops 14%
Primary Sector

Scott Technology's revenue drops 14%

Its long term strategy is not far away.

Riley Kennedy 16 Apr 2025